Kamada (KMDA) VP Nir Eran discloses initial share and option holdings

(Neutral)

Form Type

Rhea-AI Filing Summary

Kamada Ltd executive Nir Eran, Vice President of Operations, has reported his initial holdings as an insider. He directly holds 10,398 Ordinary Shares. He also holds options to purchase Ordinary Shares, including a grant for 22,500 shares at an exercise price of 6.1500 expiring on August 28, 2028, and additional grants for 22,500 underlying shares each at an exercise price of 7.5500 expiring on October 22, 2035, with exercise eligibility beginning on various dates between October 22, 2026 and October 22, 2029. The options are exercisable using a net-exercise method, and the exercise prices shown in U.S. dollars are convenience translations from NIS using the Bank of Israel exchange rate as of March 13, 2026.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Nir Eran

Role Vice President, Operations

Type	Security	Shares	Price	Value
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Options to purchase Ordinary Shares	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Options to purchase Ordinary Shares — 112,500 shares (Direct); Ordinary Shares — 10,398 shares (Direct)

Footnotes (2)

F1. These options to purchase ordinary shares are exercisable using a net-exercise method
F2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Understanding Insider Trading Forms →

Accepted by SEC EDGAR 03/16/2026 - 07:04 AM

FAQ

What insider holdings did Kamada (KMDA) VP Nir Eran report on Form 3?

Nir Eran reported direct ownership of 10,398 Ordinary Shares. He also disclosed multiple option grants to purchase Ordinary Shares, each for 22,500 underlying shares, at exercise prices of 6.1500 and 7.5500 per share with expirations in 2028 and 2035.

What stock options does Kamada (KMDA) executive Nir Eran hold?

He holds options to purchase Ordinary Shares, including a 22,500-share grant at 6.1500 per share expiring in 2028, and several 22,500-share grants at 7.5500 per share expiring in 2035, with exercise dates staggered from 2026 through 2029.

How many Kamada (KMDA) Ordinary Shares does Nir Eran directly own?

Nir Eran directly owns 10,398 Ordinary Shares. This figure reflects his reported beneficial ownership of the company’s Ordinary Shares as of the Form 3 filing date, separate from any additional shares that could be acquired through his outstanding stock option grants.

How are the exercise prices for Kamada (KMDA) options translated in Nir Eran’s filing?

Exercise prices are presented in U.S. dollars as a convenience translation from NIS. The filing states they are based on the representative exchange rate of the Bank of Israel as of March 13, 2026, ensuring consistent currency presentation for investors.

What exercise method applies to Nir Eran’s Kamada (KMDA) stock options?

The options to purchase Ordinary Shares are exercisable using a net-exercise method. Under this approach, upon exercise, only the net shares after covering the exercise cost are delivered, which can reduce the cash required from the option holder.

Do Nir Eran’s Kamada (KMDA) holdings on Form 3 show any recent insider buying or selling?

The disclosure lists holdings rather than specific buy or sell transactions. It reports his existing Ordinary Share position and outstanding option grants, without labeling any entry as a purchase, sale, gift, or other transaction that changes ownership.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Nir Eran

(Last)

(First)

(Middle)

13 ARBEL ST.

(Street)

ZUR-YIGAL

4486200

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/16/2026

3. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Vice President, Operations

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	10,398	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options to purchase Ordinary Shares⁽¹⁾	02/28/2026	08/28/2028	Ordinary Shares	22,500	$6.15⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2026	10/22/2035	Ordinary Shares	22,500	$7.55⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2027	10/22/2035	Ordinary Shares	22,500	$7.55⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2028	10/22/2035	Ordinary Shares	22,500	$7.55⁽²⁾	D
Options to purchase Ordinary Shares⁽¹⁾	10/22/2029	10/22/2035	Ordinary Shares	22,500	$7.55⁽²⁾	D

Explanation of Responses:

1. These options to purchase ordinary shares are exercisable using a net-exercise method

2. All exercise prices presented in U.S. dollars represent a convenience translation from NIS based on the representative exchange rate of the Bank of Israel as of March 13, 2026.

	/s/ Eran Nir	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR